Skip to Content

Endo to Announce Fourth Quarter 2015 Financial Results on February 29, 2016

February 16, 2016

DUBLIN, Feb. 16, 2016 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its fourth quarter 2015 financial results before the open of the U.S. financial markets on February 29, 2016 and members of its senior management team will host a conference call and webcast at 8:30 a.m. ET that day.

The dial-in number to access the call is U.S./Canada (877) 456-0441, International (929) 387-3793, and the passcode is 50028537. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from February 29, 2016 at 12:30 p.m. ET until 11:59 p.m. ET on March 14, 2016 by dialing (404) 537-3406 (U.S./Canada) or (855) 859-2056 (International) and entering the passcode 50028537.

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 11:59 p.m. ET on March 14, 2016. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo International plc
Endo International plc (NASDAQ: ENDP) (TSX: ENL) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-announce-fourth-quarter-2015-financial-results-on-february-29-2016-300220465.html

SOURCE Endo Pharmaceuticals Inc.

Endo International plc: Investors/Media: Keri P. Mattox, (484) 216-7912; Media: Heather Zoumas-Lubeski, (484) 216-6829